Current use and costs of electronic health records for clinical trial research: a descriptive study by Mc Cord, Kimberly A, Ewald, Hannah, Ladanie, Aviv, Briel, Matthias, Speich, Benjamin, Bucher, Heiner C, Hemkens, Lars G

Get full text

The Comparative Effectiveness of Innovative Treatments for Cancer (CEIT-Cancer) project: Rationale and design of the database and the collection of evidence available at approval o... by Ladanie, Aviv, Speich, Benjamin, Naudet, Florian, Agarwal, Arnav, Pereira, Tiago V, Sclafani, Francesco, Martin-Liberal, Juan, Schmid, Thomas, Ewald, Hannah, Ioannidis, John P A, Bucher, Heiner C, Kasenda, Benjamin, Hemkens, Lars G

Get full text

How to use FDA drug approval documents for evidence syntheses by Ladanie, Aviv, Ewald, Hannah, Kasenda, Benjamin, Hemkens, Lars G

Get full text

Interpretation of epidemiologic studies very often lacked adequate consideration of confounding by Hemkens, Lars G., Ewald, Hannah, Naudet, Florian, Ladanie, Aviv, Shaw, Jonathan G., Sajeev, Gautam, Ioannidis, John P.A.

Get full text

Nonrandomized studies using causal-modeling may give different answers than RCTs: a meta-epidemiological study by Ewald, Hannah, Ioannidis, John P.A., Ladanie, Aviv, Mc Cord, Kimberly, Bucher, Heiner C., Hemkens, Lars G.

Get full text

Single pivotal trials with few corroborating characteristics were used for FDA approval of cancer therapies by Ladanie, Aviv, Speich, Benjamin, Briel, Matthias, Sclafani, Francesco, Bucher, Heiner C., Agarwal, Arnav, Ioannidis, John P.A., Pereira, Tiago V., Kasenda, Benjamin, Hemkens, Lars G.

Get full text

Marginal structural models and other analyses allow multiple estimates of treatment effects in randomized clinical trials: Meta-epidemiological analysis by Ewald, Hannah, Speich, Benjamin, Ladanie, Aviv, Bucher, Heiner C., Ioannidis, John P.A., Hemkens, Lars G.

Get full text

Off-label treatments were not consistently better or worse than approved drug treatments in randomized trials by Ladanie, Aviv, Ioannidis, John P.A., Stafford, Randall S., Ewald, Hannah, Bucher, Heiner C., Hemkens, Lars G.

Get full text

Clinical Trial Evidence Supporting US Food and Drug Administration Approval of Novel Cancer Therapies Between 2000 and 2016 by Ladanie, Aviv, Schmitt, Andreas M, Speich, Benjamin, Naudet, Florian, Agarwal, Arnav, Pereira, Tiago V, Sclafani, Francesco, Herbrand, Amanda K, Briel, Matthias, Martin-Liberal, Juan, Schmid, Thomas, Ewald, Hannah, Ioannidis, John P A, Bucher, Heiner C, Kasenda, Benjamin, Hemkens, Lars G

Get full text

Off-label prescription: experience is a gloomy lantern that does not even illuminate its bearer. Author response by Ladanie, Aviv, Ioannidis, John P.A., Stafford, Randall S., Ewald, Hannah, Bucher, Heiner C., Hemkens, Lars G., Hemkens, Lars G.

Get full text